CGEM

NASD Cullinan Therapeutics, Inc.
Oct 3, 2026 · 7:21 PM ET EOD Market Closed

$15.51 ↑ +0.00 (+0.00%) Trading Up from the previous close of $15.51, $0.05 below the day’s high of $15.56

YTD change
+49.86%
vs 20-day SMA
-19.02%
vs 200-day SMA
+1.17%

Price ranges

Previous day
$14.59 $15.56
open $14.76 close $15.51
+$0.75 (+5.08%)
Today
$14.59 $15.56
$15.51
Past week
$14.20 $15.78
from $15.44 now $15.51
+$0.07 (+0.45%)
Past month
$14.20 $22.68
from $22.33 now $15.51
-$6.82 (-30.54%)
This year
$9.41 $23.19
from $10.35 now $15.51
+$5.16 (+49.86%)

Price & Performance

+0.59 (+3.95%) / 6M

$11.18$15.39$19.61$23.82Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 74.1% away from all-time highs of $59.85
  • CGEM is up 50% since the beginning of the year
  • CGEM is up 170% over the past 12 months
  • CGEM is down 31% over the past 1 month
  • 17% of all CGEM investors are betting against CGEM

CGEM reads neutral: price sits above one of the two key moving averages, the 12-month move is +162.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.81
Earnings momentum +4.3% Quarterly EPS growth
Quarterly change +4.3%

Valuation

P/E ratio N/A
Enterprise value $568.0M
Beta -0.53

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$334.5M
Debt$2.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $998.1M

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $403.04 -1.04%
MRNA Moderna, Inc. $190.01 +0.57%
RVMD Revolution Medicines, Inc. $206.64 +0.36%
ROIV Roivant Sciences Ltd. $35.72 +0.62%
BNTX BioNTech SE Sponsored ADR $96.90 +0.05%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.